145 related articles for article (PubMed ID: 9390658)
1. Effects of extracranial radioactivity on measurement of cerebral glucose metabolism by rat-PET with [18F]-2-fluoro-2-deoxy-D-glucose.
Kuge Y; Miyake Y; Minematsu K; Yamaguchi T; Hasegawa Y
J Cereb Blood Flow Metab; 1997 Nov; 17(11):1261-2. PubMed ID: 9390658
[No Abstract] [Full Text] [Related]
2. Measurement of cerebral glucose metabolic rates in the anesthetized rat by dynamic scanning with 18F-FDG, the ATLAS small animal PET scanner, and arterial blood sampling.
Shimoji K; Ravasi L; Schmidt K; Soto-Montenegro ML; Esaki T; Seidel J; Jagoda E; Sokoloff L; Green MV; Eckelman WC
J Nucl Med; 2004 Apr; 45(4):665-72. PubMed ID: 15073264
[TBL] [Abstract][Full Text] [Related]
3. Computer phantom study of brain PET glucose metabolism imaging using a rotating SPECT/PET camera.
McGoron AJ; Mao X; Georgiou MF; Kuluz JW
Comput Biol Med; 2005 Jul; 35(6):511-31. PubMed ID: 15780862
[TBL] [Abstract][Full Text] [Related]
4. Harderian gland adenectomy: a method to eliminate confounding radio-opacity in the assessment of rat brain metabolism by 18F-fluoro-2-deoxy-D-glucose positron emission tomography.
Brammer DW; Riley JM; Kreuser SC; Zasadny KR; Callahan MJ; Davis MD
J Am Assoc Lab Anim Sci; 2007 Sep; 46(5):42-5. PubMed ID: 17877327
[TBL] [Abstract][Full Text] [Related]
5. Decreased regional cerebral metabolic rate for glucose in systemic lupus erythematosus patients with psychiatric symptoms.
Komatsu N; Kodama K; Yamanouchi N; Okada S; Noda S; Nawata Y; Takabayashi K; Iwamoto I; Saito Y; Uchida Y; Ito H; Yoshikawa K; Sato T
Eur Neurol; 1999 Jul; 42(1):41-8. PubMed ID: 10394047
[TBL] [Abstract][Full Text] [Related]
6. Application of positron emission tomography to determine cerebral glucose utilization in conscious infant monkeys.
Moore AH; Cherry SR; Pollack DB; Hovda DA; Phelps ME
J Neurosci Methods; 1999 May; 88(2):123-33. PubMed ID: 10389658
[TBL] [Abstract][Full Text] [Related]
7. The rate-limiting step for tumor [18F]fluoro-2-deoxy-D-glucose (FDG) incorporation.
Smith TA
Nucl Med Biol; 2001 Jan; 28(1):1-4. PubMed ID: 11182558
[No Abstract] [Full Text] [Related]
8. Double-injection FDG method to measure cerebral glucose metabolism twice in a single procedure.
Nishizawa S; Kuwabara H; Ueno M; Shimono T; Toyoda H; Konishi J
Ann Nucl Med; 2001 Jun; 15(3):203-7. PubMed ID: 11545189
[TBL] [Abstract][Full Text] [Related]
9. Detection of alterations in brain glucose metabolism by positron emission tomography in Takayasu's arteritis.
Weiner SM; Vaith P; Walker UA; Brink I
Eur J Nucl Med Mol Imaging; 2004 Feb; 31(2):300-2. PubMed ID: 15129714
[No Abstract] [Full Text] [Related]
10. Evaluation of 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in rat models with hepatocellular carcinoma with liver cirrhosis.
Park SI; Lee JH; Ham HJ; Jung YJ; Park MS; Lee J; Maeng LS; Chung YA; Jang KS
Biomed Mater Eng; 2015; 26 Suppl 1():S1669-76. PubMed ID: 26405933
[TBL] [Abstract][Full Text] [Related]
11. Nonprosthesis orthopedic applications of (18)F fluoro-2-deoxy-D-glucose PET in the detection of osteomyelitis.
Meller J; Sahlmann CO; Liersch T; Hao Tang P; Alavi A
Radiol Clin North Am; 2007 Jul; 45(4):719-33, vii-viii. PubMed ID: 17706536
[TBL] [Abstract][Full Text] [Related]
12. Cerebral blood flow and glucose metabolism in hypothyroidism: a positron emission tomography study.
Constant EL; de Volder AG; Ivanoiu A; Bol A; Labar D; Seghers A; Cosnard G; Melin J; Daumerie C
J Clin Endocrinol Metab; 2001 Aug; 86(8):3864-70. PubMed ID: 11502825
[TBL] [Abstract][Full Text] [Related]
13. Cerebral glucose utilization measured by positron emission tomography. [1-11C]-D-glucose compared with [2-18F]-2-fluoro-2-deoxy-D-glucose.
Blomqvist G; Stone-Elander S; Halldin C; Roland PE; Swahn CG; Haaparanta M; Solin O; Lindqvist M; Widén L
Acta Radiol Suppl; 1991; 376():171-2. PubMed ID: 1666769
[No Abstract] [Full Text] [Related]
14. Glucose metabolism in human malignant gliomas measured quantitatively with PET, 1-[C-11]glucose and FDG: analysis of the FDG lumped constant.
Spence AM; Muzi M; Graham MM; O'Sullivan F; Krohn KA; Link JM; Lewellen TK; Lewellen B; Freeman SD; Berger MS; Ojemann GA
J Nucl Med; 1998 Mar; 39(3):440-8. PubMed ID: 9529289
[TBL] [Abstract][Full Text] [Related]
15. Regional cerebral glucose metabolism and blood flow in a patient with Marchiafava-Bignami disease.
Ishii K; Ikerjiri Y; Sasaki M; Kitagaki H; Mori E
AJNR Am J Neuroradiol; 1999 Aug; 20(7):1249-51. PubMed ID: 10472981
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of 2-[18F]fluoro-2-deoxy-L-glucose and positron emission tomography studies in monkeys.
Meng J; Elmaleh DR; Jyawook S; Weiss S; Alpert NM; Babich JW; Tompkins RG; Fischman AJ
Nucl Med Biol; 1994 May; 21(4):633-40. PubMed ID: 9234321
[TBL] [Abstract][Full Text] [Related]
17. 18FDG imaging of giant cell arteritis: usefulness of whole-body plus brain PET.
Belhocine T
Eur J Nucl Med Mol Imaging; 2004 Jul; 31(7):1055-6. PubMed ID: 15118843
[No Abstract] [Full Text] [Related]
18. Impaired cerebral glucose metabolism in myotonic dystrophy: a triplet-size dependent phenomenon.
Annane D; Fiorelli M; Mazoyer B; Pappata S; Eymard B; Radvanyi H; Junien C; Fardeau M; Merlet P; Gajdos P; Syrota A; Sansom Y; Duboc D
Neuromuscul Disord; 1998 Feb; 8(1):39-45. PubMed ID: 9565989
[TBL] [Abstract][Full Text] [Related]
19. Uncoupling of fatty acid and glucose metabolism in malignant lymphoma: a PET study.
Nuutinen J; Minn H; Bergman J; Haaparanta M; Ruotasalainen U; Laine H; Knuuti J
Br J Cancer; 1999 May; 80(3-4):513-8. PubMed ID: 10408861
[TBL] [Abstract][Full Text] [Related]
20. Anatomolecular imaging with 2-deoxy-2-[18F]fluoro-D-glucose: bench to outpatient center.
Wahl RL
Mol Imaging Biol; 2003; 5(2):49-56. PubMed ID: 14499144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
